About Elanco
Elanco is a company based in Greenfield (United States) founded in 1954. The company has 9,450 employees as of December 31, 2024. Elanco has completed 4 acquisitions, including Aratana, KindredBio and Lah.de. Elanco offers products and services including Animal Health Solutions and Pet Care Products.
- Headquarter Greenfield, United States
- Employees 9450 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Elanco Animal Health Incorporated
-
Annual Revenue
$4.44 B (USD)0.5as on Dec 31, 2024
-
Net Profit
$338 M (USD)0as on Dec 31, 2024
-
EBITDA
$913 M (USD)-10.49as on Dec 31, 2024
-
Latest Funding Round
$170.86 K (USD), Grant
Apr 23, 2021
-
Investors
European Union
& 2 more
-
Employee Count
9450
as on Dec 31, 2024
-
Investments & Acquisitions
Aratana
& 3 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Elanco
Elanco is a publicly listed company on the NYSE with ticker symbol ELAN in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Elanco
Elanco offers a comprehensive portfolio of products and services, including Animal Health Solutions and Pet Care Products.
Innovative solutions are provided for farm animals to address health challenges and promote wellbeing.
Products are offered for pet owners and veterinarians to manage diseases and improve animal health outcomes.
People of Elanco
Unlock access to complete
Unlock access to complete
Software Development Team
206 people
Leadership Team
81 people
Sales and Marketing
63 people
Finance and Accounting
48 people
Human Resources and Administration
37 people
Senior Team
31 people
Legal and Compliance
23 people
Product Management Team
23 people
Unlock access to complete
Funding Insights of Elanco
Investors in Elanco
Elanco has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include European Union, GrandEst and Sachem Head.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Access and development services for government programs are provided.
|
Locked | Locked | Locked | |
|
Investment firm offering capital management and advisory for clients in finance.
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for Elanco
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Elanco
Elanco has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include Aratana, KindredBio and Lah.de.
Investment portfolio details for Elanco
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Veterinary antibodies for cats, dogs, and horses are developed.
|
Locked | Locked | 2012 | Locked | |
|
Therapeutics to treat osteoarthritis, inappetence, cancer, & viral infections in pets.
|
Locked | Locked | 2010 | Locked | |
|
Vaccination biological products for livestock are developed and marketed.
|
Locked | Locked | 2003 | Locked |
Complete acquisition details for Elanco
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Elanco
Detailed financials for Elanco
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Elanco Comparisons
Peer comparison for Elanco
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Elanco
Detailed competitors of Elanco
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Elanco
Complete news archive for Elanco
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Elanco
Elanco was founded in 1954 and raised its 1st funding round 64 years after it was founded.
Elanco is headquartered in Greenfield, United States.
As of Dec 31, 2024, the latest employee count at Elanco is 9,450.
Annual revenue of Elanco is $4.44B as on Dec 31, 2024.
Elanco was established in 1954 and is headquartered in Greenfield, United States. Operations are centered on the animal health sector, where veterinary medicines and nutritional food products are developed and distributed. Focus is placed on solutions for livestock and companion animals, with services extending to global markets. Leadership includes Victor Guevara as Chief Financial Officer, overseeing financial strategies.
Elanco offers Animal Health Solutions and Pet Care Products.
Yes, Elanco is publicly traded on NYSE under the ticker symbol ELAN.
Elanco has made 4 acquisitions, including Aratana, KindredBio, and Lah.de.
Elanco has 3 investors. Key investors include European Union, GrandEst, and Sachem Head.
The ticker symbol of Elanco is ELAN on NYSE.